Moderate-Dose Exercise Protects Against Heart Failure via Apelin/NLRP3 Mediated Inflammation
Related Experiment Videos
Dongli Gao1, Maoshuai Zhang2, Yuanhao Li1
1Department of Cardiology, Life Science Research Center, The First Affiliated Hospital of Xinxiang Medical University, 453100 Xinxiang, Henan, China.
Background:
Heart failure (HF) remains a major cause of cardiovascular mortality worldwide, imposing a substantial burden on healthcare systems. Although physical exercise is known to exert cardioprotective effects, its underlying mechanisms are not fully understood.
Methods:
We established a post-myocardial infarction (MI) HF mouse model via coronary artery ligation, followed by an 8-week exercise regimen at different intensities. Multi-omics sequencing was performed to identify alterations in inflammatory and metabolic pathways.
Results:
Moderate-dose exercise preserved cardiac function and attenuated ventricular remodeling. Metabolomic analysis indicated modulation of lipid metabolism and inflammation via the Apelin pathway. Transcriptomics revealed that the nucleotide-binding oligomerization domain (NOD)-like receptor signaling pathway, which was elevated after MI, was suppressed by moderate-dose exercise. Additionally, Nuclear factor erythroid 2-related factor 2 (Nrf2)-a key transcription factor regulating antioxidant and anti-inflammatory responses-was upregulated in the moderate-exercise group.
Conclusions:
Moderate-dose exercise protects against HF in mice by regulating lipid metabolism and inflammatory pathways. These findings support the standardization of exercise therapy for secondary prevention of cardiovascular disease.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure Drugs: β-Blockers
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management
Heart Failure Drugs: Diuretics